This Phase III, randomized study will determine whether combining gemcitabine with 5-FU provides survival benefit in patients with advanced pancreatic carcinoma when compared to gemcitabine alone. Data will be collected to evaluate pain symptoms.
Showing the most recent 10 out of 470 publications